0.0 z 5 hvězdiček
měkká vazbaKniha ( pevná vazba )
- Dostupné u dodavatele
- Doručení V pondělí 9. 2. předáme dopravci
- Osobní odběr ZDARMA ( Vyberte prodejnu )
957 Kč s DPH
Jsme transparentní
How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective. Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel—but what is often missing from the popular… Přejít na celý popis
K tomuto produktu zákazníci kupují
-
Book about Getting Older
-
The Power of Hormones
-
Inheritance
-
What Women Want
-
May Contain Lies
-
Novinka Unravelling Trauma and Weaving Resilience with Systemic and Narrative Therapy
-
The Ultimate Hidden Truth of the World
-
The Glass Cliff
-
Being Human
-
The Activist Leader: A New Mindset for Doing Business
-
The Skeptics' Guide to the Future
-
Freedom Is A Constant Struggle
-
The Psychology of Money
-
Five Rings Illustrated
-
Surrounded by Psychopaths
-
The Anxious Generation: How the Great Rewiring of Childhood Is Causing an Epidemic of Mental Illness
-
Tuesdays With Morrie
-
Travels with Epicurus
-
Food Rules
How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective. Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel—but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which• promote novel cancer therapies long before credible data are available to support such treatment; and• exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars. Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration. This is a book about how the actions of human beings—our policies, our standards of evidence, and our drug regulation—incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says, • more cancer clinical trials should measure outcomes that actually matter to people with cancer;• patients on those trials should look more like actual global citizens;• we need drug regulators to raise, not perpetually lower, the bar for approval; and• we need unbiased patient advocates and experts. This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer—and how we can avoid repeating the policy and practice mistakes of the past.
- Nakladatel
- Johns Hopkins University Press
- Rozměr
- 240 x 161 x 28
- jazyk
- angličtina
- Počet stran
- 304
- Hmotnost
- 556 g
- isbn
- 978-1-4214-3763-7
- Vazba
- pevná vazba
- datum vydání
- 21.04.2020
- ean
- 9781421437637
Hodnocení a recenze čtenářů Nápověda
0.0 z 5 0 hodnocení čtenářů
0× 5 hvězdiček 0× 4 hvězdičky 0× 3 hvězdičky 0× 2 hvězdičky 0× 1 hvezdička
Přidejte své hodnocení knihy
Vývoj ceny Nápověda
Získejte přehled o vývoji ceny za posledních 60 dní.
Články, které stojí za pozornost
-
Neotvírat!!! Kouše! Proč děti tuhle knihu milují?
-
Urbex, smrt a švédský chlad – vítejte v Rezavém lese
-
Ve spárech temnoty: Temnější a vyzrálejší návrat do Everfallu | RECENZE
-
Pro fanoušky Heated Rivalry máme skvělou zprávu! Vyjde další kniha série Game Changers
-
Little Stranger: Utíkej, holčičko - temná romance, která není pro každého| RECENZE
-
Moje lepší polovička – netradiční román o lásce, rodičovství a odvaze | RECENZE
-
6 nejčtivějších novinek tohoto ledna
-
10 nejprodávanějších deskových her roku 2025 v síti Knihy Dobrovský
-
10 nejprodávanějších e-knih roku 2025 u Knihy Dobrovský
-
10 nejprodávanějších knih roku 2025 v síti knihkupectví Knihy Dobrovský
-
Láska jako ve filmu - akorát že vůbec | RECENZE
-
Jsi moje - kniha, která voní po skořici a druhých šancích